Ginsenoside Rg3 treats acute radiation proctitis through the TLR4/MyD88/NF-κB pathway and regulation of intestinal flora

ObjectivesThis study aimed to investigate the protective effect of ginsenoside Rg3 (GRg3) against acute radiation proctitis (ARP) in rats.MethodsWistar rats were randomly divided into control, model, dexamethasone-positive, GRg3 low-dose, GRg3 medium-dose, and GRg3 high-dose groups. The ARP rat mode...

Full description

Bibliographic Details
Main Authors: Xiaoyu Duan, Hongyi Cai, Tingting Hu, Lili Lin, Lu Zeng, Huixia Wang, Lei Cao, Xuxia Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2022.1028576/full
_version_ 1797959796355235840
author Xiaoyu Duan
Hongyi Cai
Tingting Hu
Lili Lin
Lu Zeng
Huixia Wang
Lei Cao
Xuxia Li
author_facet Xiaoyu Duan
Hongyi Cai
Tingting Hu
Lili Lin
Lu Zeng
Huixia Wang
Lei Cao
Xuxia Li
author_sort Xiaoyu Duan
collection DOAJ
description ObjectivesThis study aimed to investigate the protective effect of ginsenoside Rg3 (GRg3) against acute radiation proctitis (ARP) in rats.MethodsWistar rats were randomly divided into control, model, dexamethasone-positive, GRg3 low-dose, GRg3 medium-dose, and GRg3 high-dose groups. The ARP rat model was established by a single 22-Gy irradiation of 6 MV) X-rays. The distribution and function of intestinal flora were detected using 16S rRNA high-throughput sequencing, rectal tissue was observed by hematoxylin and eosin (H&E) staining, the expression of interleukin 1β (IL-1β) and IL-10 inflammatory factors was detected by ELISA, and mRNA and protein expression of toll-like receptor 4 (TLR4), myeloid differentiation primary response 88 (MyD88), and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) were detected by RT-qPCR and Western blotting, respectively.ResultsGRg3 improved the symptoms of ARP in rats in a dose-dependent manner. The species distribution of intestinal flora in GRg3 rats was significantly different from that in ARP rats. These differences were more significant in the high-dose group, where the numbers of Ruminococcus, Lactobacillus, and other beneficial bacteria were significantly increased, whereas those of Escherichia, Alloprevotella, and other harmful bacteria were decreased. In addition, GRg3 was closely related to amino acid metabolism. After GRg3 treatment, the mRNA and protein expression of TLR4, MyD88, and NF-κB in rectal tissue was significantly down-regulated, and the level of downstream inflammatory factor IL-1β decreased, whereas that of IL-10 increased.ConclusionOur study indicated GRg3 as a new compound for the treatment of ARP by inhibiting the TLR4/MyD88/NF-κB pathway, down-regulating the expression of proinflammatory factors, thus effectively regulating intestinal flora and reducing inflammatory reactions.
first_indexed 2024-04-11T00:37:48Z
format Article
id doaj.art-2a227caa01654c649a24bad29b44b9b0
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-04-11T00:37:48Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-2a227caa01654c649a24bad29b44b9b02023-01-06T14:45:33ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882023-01-011210.3389/fcimb.2022.10285761028576Ginsenoside Rg3 treats acute radiation proctitis through the TLR4/MyD88/NF-κB pathway and regulation of intestinal floraXiaoyu Duan0Hongyi Cai1Tingting Hu2Lili Lin3Lu Zeng4Huixia Wang5Lei Cao6Xuxia Li7The First Clinical Medical College of Gansu University of Chinese Medicine (Gansu Provincial Hospital), Lanzhou, ChinaDepartment of Radiotherapy, Gansu Provincial Hospital, Lanzhou, ChinaDepartment of Radiotherapy, Gansu Provincial Hospital, Lanzhou, ChinaThe First Clinical Medical College of Gansu University of Chinese Medicine (Gansu Provincial Hospital), Lanzhou, ChinaThe First Clinical Medical College of Gansu University of Chinese Medicine (Gansu Provincial Hospital), Lanzhou, ChinaThe First Clinical Medical College of Gansu University of Chinese Medicine (Gansu Provincial Hospital), Lanzhou, ChinaThe First Clinical Medical College of Gansu University of Chinese Medicine (Gansu Provincial Hospital), Lanzhou, ChinaThe First Clinical Medical College of Gansu University of Chinese Medicine (Gansu Provincial Hospital), Lanzhou, ChinaObjectivesThis study aimed to investigate the protective effect of ginsenoside Rg3 (GRg3) against acute radiation proctitis (ARP) in rats.MethodsWistar rats were randomly divided into control, model, dexamethasone-positive, GRg3 low-dose, GRg3 medium-dose, and GRg3 high-dose groups. The ARP rat model was established by a single 22-Gy irradiation of 6 MV) X-rays. The distribution and function of intestinal flora were detected using 16S rRNA high-throughput sequencing, rectal tissue was observed by hematoxylin and eosin (H&E) staining, the expression of interleukin 1β (IL-1β) and IL-10 inflammatory factors was detected by ELISA, and mRNA and protein expression of toll-like receptor 4 (TLR4), myeloid differentiation primary response 88 (MyD88), and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) were detected by RT-qPCR and Western blotting, respectively.ResultsGRg3 improved the symptoms of ARP in rats in a dose-dependent manner. The species distribution of intestinal flora in GRg3 rats was significantly different from that in ARP rats. These differences were more significant in the high-dose group, where the numbers of Ruminococcus, Lactobacillus, and other beneficial bacteria were significantly increased, whereas those of Escherichia, Alloprevotella, and other harmful bacteria were decreased. In addition, GRg3 was closely related to amino acid metabolism. After GRg3 treatment, the mRNA and protein expression of TLR4, MyD88, and NF-κB in rectal tissue was significantly down-regulated, and the level of downstream inflammatory factor IL-1β decreased, whereas that of IL-10 increased.ConclusionOur study indicated GRg3 as a new compound for the treatment of ARP by inhibiting the TLR4/MyD88/NF-κB pathway, down-regulating the expression of proinflammatory factors, thus effectively regulating intestinal flora and reducing inflammatory reactions.https://www.frontiersin.org/articles/10.3389/fcimb.2022.1028576/fullTLR4/MyD88/NF-κB signal pathwayginsenoside Rg3acute radiation proctitisintestinal microfloramechanism
spellingShingle Xiaoyu Duan
Hongyi Cai
Tingting Hu
Lili Lin
Lu Zeng
Huixia Wang
Lei Cao
Xuxia Li
Ginsenoside Rg3 treats acute radiation proctitis through the TLR4/MyD88/NF-κB pathway and regulation of intestinal flora
Frontiers in Cellular and Infection Microbiology
TLR4/MyD88/NF-κB signal pathway
ginsenoside Rg3
acute radiation proctitis
intestinal microflora
mechanism
title Ginsenoside Rg3 treats acute radiation proctitis through the TLR4/MyD88/NF-κB pathway and regulation of intestinal flora
title_full Ginsenoside Rg3 treats acute radiation proctitis through the TLR4/MyD88/NF-κB pathway and regulation of intestinal flora
title_fullStr Ginsenoside Rg3 treats acute radiation proctitis through the TLR4/MyD88/NF-κB pathway and regulation of intestinal flora
title_full_unstemmed Ginsenoside Rg3 treats acute radiation proctitis through the TLR4/MyD88/NF-κB pathway and regulation of intestinal flora
title_short Ginsenoside Rg3 treats acute radiation proctitis through the TLR4/MyD88/NF-κB pathway and regulation of intestinal flora
title_sort ginsenoside rg3 treats acute radiation proctitis through the tlr4 myd88 nf κb pathway and regulation of intestinal flora
topic TLR4/MyD88/NF-κB signal pathway
ginsenoside Rg3
acute radiation proctitis
intestinal microflora
mechanism
url https://www.frontiersin.org/articles/10.3389/fcimb.2022.1028576/full
work_keys_str_mv AT xiaoyuduan ginsenosiderg3treatsacuteradiationproctitisthroughthetlr4myd88nfkbpathwayandregulationofintestinalflora
AT hongyicai ginsenosiderg3treatsacuteradiationproctitisthroughthetlr4myd88nfkbpathwayandregulationofintestinalflora
AT tingtinghu ginsenosiderg3treatsacuteradiationproctitisthroughthetlr4myd88nfkbpathwayandregulationofintestinalflora
AT lililin ginsenosiderg3treatsacuteradiationproctitisthroughthetlr4myd88nfkbpathwayandregulationofintestinalflora
AT luzeng ginsenosiderg3treatsacuteradiationproctitisthroughthetlr4myd88nfkbpathwayandregulationofintestinalflora
AT huixiawang ginsenosiderg3treatsacuteradiationproctitisthroughthetlr4myd88nfkbpathwayandregulationofintestinalflora
AT leicao ginsenosiderg3treatsacuteradiationproctitisthroughthetlr4myd88nfkbpathwayandregulationofintestinalflora
AT xuxiali ginsenosiderg3treatsacuteradiationproctitisthroughthetlr4myd88nfkbpathwayandregulationofintestinalflora